9Indexed trials
mesh condition
Rare Diseases
Intelligence
Rare Diseases intelligence: 9 indexed trials, 4 recruiting studies, 9 sponsors across 6 countries.
4Recruiting
9Sponsors
6Countries
Leading sponsors
Connecta Therapeutics, S.L.11 recruiting
Istituto Auxologico Italiano11 recruiting
Johns Hopkins University10 recruiting
National Center for Research Resources (NCRR)10 recruiting
National Institute of Mental Health (NIMH)10 recruiting
Sanford Health11 recruiting
UMC Utrecht11 recruiting
University Hospital, Strasbourg, France10 recruiting
University of California, Los Angeles10 recruiting
Geographic activity
United States2trials
Australia1trials
France1trials
Italy1trials
Netherlands1trials
Spain1trials
Leading interventions
CTH1201trials
CTH120 placebo hard capsules1trials
Cannabidiol (CBD) oral solution1trials
Glucose1trials
Individualized in home parent training1trials
Questionnaires, clinical scales and instrumental tests1trials
albendazole1trials
dexamethasone1trials
intensive one-on-one behavioral treatment1trials
monoclonal antibody M-T4121trials
phenytoin1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.